. Author manuscript; available in PMC: 2013 May 6.

Published in final edited form as: Clin Cancer Res. 2009 Nov 3;15(22):7099–7105. doi: 10.1158/1078-0432.CCR-09-1722

Table 3.

Hormone levels over time among all patients

Hormone	Baseline value	Month 1		Month 2		Month 3
Hormone	Baseline value	Value	Percentage change from baseline	Value	Percentage change from baseline	Value	Percentage change from baseline
Patients, n	41	33	30	28	24	28	24
Androstenedione (ng/mL)	0.84 (0.61, 1.10)	0.22 (0.20, 0.36)	−56 (−75, −43)	0.27 (0.20, 0.32)	−68 (−74, −49)	0.25 (0.20, 0.31)	−58 (−77, −49)
DHEAS (ng/mL)	599 (340, 1206)	65 (36, 125)	−89 (−94, −70)	65 (37, 106)	−92 (−94, −77)	65 (35, 100)	−90 (−94, −81)
Testosterone (ng/mL)	0.37 (0.26, 0.47)	0.13 (0.10, 0.15)	−66 (−72, −55)	0.11 (0.9, 0.14)	−68 (−73, −54)	0.12 (0.10, 0.19)	−64 (−72, −45)
DHT^* (pg/mL)	2.6 (<2.0, 3.8)	<2.0 (<2.0, <2.0)

NOTE: Median and interquartile range (25th, 75th percentiles).

For DHT, n = 33 at baseline, n = 32 at month 1, and n = 29 for percent change.